A client is taking Somatropin to stimulate growth. The healthcare provider should plan to monitor the client's urine for which of the following?

Questions 122

ATI RN

ATI RN Test Bank

ATI Pharmacology Proctored Exam 2019 Questions

Question 1 of 5

A client is taking Somatropin to stimulate growth. The healthcare provider should plan to monitor the client's urine for which of the following?

Correct Answer: D

Rationale: When a client is taking Somatropin to stimulate growth, monitoring calcium levels in the urine is crucial. Excessive calcium excretion can occur in the urine of clients taking Somatropin, increasing the risk of renal calculi. Therefore, monitoring calcium levels is essential to assess for potential kidney stone formation.

Question 2 of 5

A client with breast cancer is being taught by a nurse about the adverse effects of chemotherapy. Which of the following statements should the nurse include?

Correct Answer: A

Rationale: The nurse should instruct the client to use a soft-bristled toothbrush to prevent bleeding, which can occur due to chemotherapy-induced thrombocytopenia. Chemotherapy can decrease platelet counts, leading to an increased risk of bleeding. Using a soft-bristled toothbrush can help prevent gum bleeding and oral trauma.

Question 3 of 5

A client has a new prescription for rituximab. Which of the following findings should the nurse instruct the client to report?

Correct Answer: B

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 4 of 5

A client is starting therapy with doxorubicin. Which of the following findings should the nurse instruct the client to report?

Correct Answer: C

Rationale: The correct answer is 'C: Sore throat.' Doxorubicin is known to have immunosuppressive effects, which can predispose the client to infections. A sore throat can be an early sign of infection, and prompt reporting to the healthcare provider is crucial to initiate appropriate interventions and prevent complications.

Question 5 of 5

A client is receiving treatment with bevacizumab. Which of the following findings should the nurse monitor?

Correct Answer: A

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions